Pain management in children with advanced cancer and during end-of-life care

Pediatric Hematology and Oncology

Volumn 27, Issue 4, 2010, Pages 257-261

  Friedrichsdorf, Stefan J ^a  

^a CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; BISPHOSPHONIC ACID DERIVATIVE; CELECOXIB; CODEINE; DEXTROPROPOXYPHENE; FENTANYL; GABAPENTIN; HYDROCODONE BITARTRATE PLUS PARACETAMOL; HYDROMORPHONE; IBUPROFEN; METHADONE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OPIATE; OXYCODONE; PARACETAMOL; PERCOCET; PETHIDINE; SPASMOLYTIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ADJUVANT THERAPY; ADVANCED CANCER; ANALGESIA; AROMATHERAPY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CHILD; CHILDHOOD CANCER; COPING BEHAVIOR; CORDOTOMY; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG MEGADOSE; DRUG METABOLISM; DRUG USE; FEEDBACK SYSTEM; HEALTH EDUCATION; HUMAN; HYPNOSIS; IMAGERY; INDIVIDUALIZATION; LIVER TOXICITY; LOW DRUG DOSE; MASSAGE; MUSIC THERAPY; NAUSEA AND VOMITING; NERVE BLOCK; NEUROSURGERY; NEUROTOXICITY; NOCICEPTION; NOTE; PATIENT CONTROLLED ANALGESIA; QUALITY OF LIFE; TERMINAL CARE; TREATMENT RESPONSE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASMS; PAIN; PALLIATIVE CARE; UNITED STATES;

EID: 77951809014     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880011003663416     Document Type: Note

References (14)

1. Ghooi RB, Ghooi SR. A mother in pain. Lancet. 1998; 352: 1625.
2. Ries LAG, Gurney JG, Linet M, et al. eds. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, National Cancer Institute, SEER Program. Bethesda, MD: NIH; 1999.
3. Li J, Thompson TD, Miller JW, et al. Cancer incidence among children and adolescents in the United States, 2001-2003. Pediatrics. 2008; 121: e1470-e1477.
4. Ries LAG, Krapcho M, Stinchcomb DG, et al, eds. SEER Cancer Statistics Review, 1975-2005. Bethesda, MD: National Cancer Institute; 2008.
5. Linet MS, Ries LA, Smith MA, et al. Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst. 1999; 91: 1051-1058.
6. Wolfe J, Grier HE, Klar N, et al. Symptoms and suffering at the end of life in children with cancer. N Engl J Med. 2000; 342: 326-333.
7. Wolfe J, Hammel JF, Edwards KE, et al. Easing of suffering in children with cancer at the end of life: is care changing? J Clin Oncol. 2008; 26: 1717-1723.
8. Wolfe J, Klar N, Grier HE, et al. Understanding of prognosis among parents of children who died of cancer: impact on treatment goals and integration of palliative care. JAMA. 2000; 284: 2469-2475.
9. Friedrichsdorf SJ, Kang TI. The management of pain in children with life-limiting illnesses. Pediatr Clin North Am. 2007; 54: 645-672.
10. WHO. Cancer Pain Relief and Palliative Care in Children. Geneva: World Health Organization; 1998.
11. American Pain Society, Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain. American Pain Society, Glenview, IL; 2008.
12. Williams DG, Patel A, Howard RF. Pharmacogenetics of codeine metabolism in an urban population of children and its implications for analgesic reliability. Br J Anaesth. 2002; 89: 839-845.
13. Koren K. Codeine, ultrarapid-metabolism genotype, and postoperative death. N Engl J Med. 2009; 8: 827-828.
14. Thorns A, Sykes N. Opioid use in last week of life and implications for end-of-life decision-making. Lancet. 2000; 356: 398-399.